Zacks Research Has Positive Outlook for DLB Q2 Earnings

Dolby Laboratories (NYSE:DLB) – Analysts at Zacks Research upped their Q2 2026 earnings estimates for shares of Dolby Laboratories in a report issued on Tuesday, December 9th. Zacks Research analyst Team now expects that the electronics maker will post earnings per share of $0.97 for the quarter, up from their previous forecast of $0.90. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.94 per share. Zacks Research also issued estimates for Dolby Laboratories’ FY2028 earnings at $3.19 EPS.

A number of other analysts have also commented on DLB. Robert W. Baird began coverage on Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price for the company. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Barrington Research lowered their price target on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 8th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $92.00.

Dolby Laboratories Trading Down 0.3%

NYSE DLB opened at $67.47 on Friday. The company has a market capitalization of $6.44 billion, a PE ratio of 25.65 and a beta of 0.89. The stock has a 50-day simple moving average of $67.15 and a 200 day simple moving average of $71.41. Dolby Laboratories has a 12 month low of $64.02 and a 12 month high of $89.66.

Dolby Laboratories (NYSE:DLB) last issued its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. The business had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.Dolby Laboratories’s quarterly revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Allworth Financial LP raised its holdings in shares of Dolby Laboratories by 99.6% in the third quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after acquiring an additional 502 shares in the last quarter. Swiss Life Asset Management Ltd purchased a new position in Dolby Laboratories during the 3rd quarter worth approximately $210,000. Advisory Services Network LLC purchased a new stake in shares of Dolby Laboratories in the third quarter worth about $102,000. XTX Topco Ltd purchased a new stake in Dolby Laboratories during the third quarter worth $741,000. Finally, Verition Fund Management LLC raised its holdings in Dolby Laboratories by 172.4% in the 3rd quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker’s stock worth $2,563,000 after purchasing an additional 22,409 shares during the period. 58.56% of the stock is currently owned by institutional investors.

Insider Activity

In related news, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $65.55, for a total value of $196,650.00. Following the completion of the transaction, the senior vice president owned 67,435 shares of the company’s stock, valued at approximately $4,420,364.25. This trade represents a 4.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP John D. Couling sold 6,164 shares of the business’s stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $66.12, for a total transaction of $407,563.68. Following the transaction, the senior vice president owned 115,338 shares in the company, valued at $7,626,148.56. This trade represents a 5.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 134,730 shares of company stock worth $9,182,352 in the last quarter. Corporate insiders own 38.39% of the company’s stock.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio (DPR) is 54.75%.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.